{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:25:52Z","timestamp":1791897952524,"version":"4.3.4"},"reference-count":72,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T00:00:00Z","timestamp":1640044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"published-print":{"date-parts":[[2022,2,15]]},"abstract":"<jats:p>The legalization of cannabis in many countries has allowed many Parkinson\u2019s disease (PD) patients to turn to cannabis as a treatment. As such there is a growing interest from the PD community to be properly guided by evidence regarding potential treatment benefits of cannabis. This systematic review and meta-analysis aims to compile the best available evidence to help guide patients and their family, clinicians and researchers make informed decisions. A systematic search of the literature was conducted in June 2021. Five randomized controlled studies and eighteen non-randomized studies investigated cannabis treatment in PD patients. No compelling evidence was found to recommend the use of cannabis in PD patients. However, a potential benefit was identified with respect to alleviation of PD related tremor, anxiety, pain, improvement of sleep quality and quality of life. Given the relative paucity of well-designed randomized studies, there is an identified need for further investigation, particularly in these areas.<\/jats:p>","DOI":"10.3233\/jpd-212923","type":"journal-article","created":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T13:01:18Z","timestamp":1640091678000},"page":"495-508","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":51,"title":["Effects of Cannabis in Parkinson\u2019s Disease: A Systematic Review and Meta-Analysis"],"prefix":"10.1177","volume":"12","author":[{"given":"Berzenn","family":"Urbi","sequence":"first","affiliation":[{"name":"Office for Research Governance and Development, Gold Coast Hospital and Health Service, QLD, Australia"},{"name":"Griffith University","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Corbett","sequence":"additional","affiliation":[{"name":"Gold Coast Hospital and Health Service","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Hughes","sequence":"additional","affiliation":[{"name":"Office for Research Governance and Development, Gold Coast Hospital and Health Service, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maame Amma","family":"Owusu","sequence":"additional","affiliation":[{"name":"Office for Research Governance and Development, Gold Coast Hospital and Health Service, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Thorning","sequence":"additional","affiliation":[{"name":"Office for Research Governance and Development, Gold Coast Hospital and Health Service, QLD, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Broadley","sequence":"additional","affiliation":[{"name":"Griffith University","place":["Australia"]},{"name":"Gold Coast Hospital and Health Service","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman","family":"Sabet","sequence":"additional","affiliation":[{"name":"Griffith University","place":["Australia"]},{"name":"Gold Coast Hospital and Health Service","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saman","family":"Heshmat","sequence":"additional","affiliation":[{"name":"Griffith University","place":["Australia"]},{"name":"University of Queensland","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,12,21]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70471-9"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-5416-4_16"},{"key":"e_1_3_4_4_2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1212\/CON.0000000000000764","article-title":"Parkinson disease","volume":"45","author":"Zesiewicz TA","year":"2019","unstructured":"ZesiewiczTA (2019) Parkinson disease. Continuum (Minneapolis, Minn) 45, 896\u2013918.","journal-title":"Continuum (Minneapolis, Minn)"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrg1831"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.13593"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddp012"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-008-9656-2"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-013-8483-x"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.3390\/antiox9010021"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2019.03.035"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2005.08.026"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2016.04.005"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1089\/can.2017.0002"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.13581"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-021-00818-4"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(99)00293-3"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(98)00368-1"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.4103\/aian.AIAN_239_17"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2007.07.021"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neures.2011.12.006"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2006.04383.x"},{"key":"e_1_3_4_23_2","first-page":"33","article-title":"Marijuana for Parkinson\u2019s disease?","volume":"16","author":"Mohanty D","year":"2019","unstructured":"MohantyD, LippmannS (2019) Marijuana for Parkinson\u2019s disease? Innov Clin Neurosci 16, 33\u201334.","journal-title":"Innov Clin Neurosci"},{"key":"e_1_3_4_24_2","unstructured":"FahnS EltonRL MembersUP (1987) Unified Parkinson\u2019s disease rating scale. In Recent developments in Parkinson\u2019s disease Fahn S Marsden CD Goldstein M Calne DB eds. Macmillan Healthcare Information New Jersey."},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22340"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2009.295"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21198"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.27303"},{"key":"e_1_3_4_29_2","unstructured":"Cochrane (2011) Cochrane Public Health Group data extraction and assessment template."},{"key":"e_1_3_4_30_2","unstructured":"HigginsJPT Savovi\u0107J PageMJ ElbersRG SterneJAC (2020) Chapter 8: Assessing risk of bias in a randomized trial. In Cochrane Handbook for Systematic Reviews of Interventions version 6.1 (updated September 2020) Higgins JPT Thomas J Chandler J Cumpston M Li T Page MJ Welch VA eds."},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1205"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/31.1.140"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000140288.48796.8E"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(13)70868-X"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881114550355"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881119895536"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25864"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.57.11.2108"},{"key":"e_1_3_4_39_2","first-page":"499","article-title":"Effects of cannabis smoking in patients with advanced Parkinson\u2019s disease and Parkinsonism","volume":"18","author":"Balash Y","year":"2011","unstructured":"BalashY, ShabtaiH, HilelA, KorczynAD, GiladiN, GurevichT (2011) Effects of cannabis smoking in patients with advanced Parkinson\u2019s disease and Parkinsonism. Eur J Neurol 18, 499.","journal-title":"Eur J Neurol"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000246"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-021-00165-y"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/874849"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.53.5.436"},{"key":"e_1_3_4_44_2","first-page":"299","article-title":"Effect of medical cannabis in Parkinson\u2019s disease: survey of patient experiences","volume":"30","author":"Gurevich T","year":"2015","unstructured":"GurevichT, BarL, RosenbergA, KnaaniJ, BaruchY, DjaldettiR (2015) Effect of medical cannabis in Parkinson\u2019s disease: survey of patient experiences. Mov Disord 30, 299.","journal-title":"Mov Disord"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2017.07.002"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1089\/can.2019.0068"},{"key":"e_1_3_4_47_2","first-page":"S531","article-title":"Open label study of cannabidiol in Parkinson\u2019s disease","volume":"32","author":"Leehey MA","year":"2017","unstructured":"LeeheyMA, LiuY, EpsteinC, HartF, BainbridgeJ, CookM, SillauS, BaudZ, NewmanH (2017) Open label study of cannabidiol in Parkinson\u2019s disease. Mov Disord 32, S531.","journal-title":"Mov Disord"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.78.1_MeetingAbstracts.PD4.005"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0000000000000016"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2020.06.033"},{"key":"e_1_3_4_51_2","unstructured":"MischleyL BennettR SextonM RicciardiG McNamesJ (2017) Cannabis and Parkinson\u2019s disease tremor. Mov Disord 32(Suppl 2) https:\/\/www.mdsabstracts.org\/abstract\/cannabis-and-parkinsons-disease-tremor\/."},{"key":"e_1_3_4_52_2","first-page":"249","article-title":"Medical cannabis in the treatment of Parkinson\u2019s disease","volume":"3","author":"Myers B","year":"2020","unstructured":"MyersB, GeistT, AladeenT, WestphalE, HartP, ZelenK, BegleyA, RainkaM, FloreaS, MechtlerL (2020) Medical cannabis in the treatment of Parkinson\u2019s disease. J Am Coll Clin Pharm 3, 249.","journal-title":"J Am Coll Clin Pharm"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.942"},{"key":"e_1_3_4_54_2","first-page":"140","article-title":"Effect of cannabis on Parkinson\u2019sdisease symptoms: Questionnaire-based study","volume":"41","author":"Venderov\u00e1 K","year":"2001","unstructured":"Venderov\u00e1K, R\u016f\u017ei\u010dkaE, Vi\u0161\u0148ovsk\u00fdP (2001) Effect of cannabis on Parkinson\u2019sdisease symptoms: Questionnaire-based study. Homeostasis 41, 140\u2013142.","journal-title":"Homeostasis"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20111"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-202260"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881108096519"},{"key":"e_1_3_4_58_2","first-page":"n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"PageMJ, McKenzieJE, BossuytPM, BoutronI, HoffmannTC, MulrowCD, ShamseerL, TetzlaffJM, AklEA, BrennanSE, ChouR, GlanvilleJ, GrimshawJM, Hr\u00f3bjartssonA, LaluMM, LiT, LoderEW, Mayo-WilsonE, McDonaldS, McGuinnessLA, StewartLA, ThomasJ, TriccoAC, WelchVA, WhitingP, MoherD (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ (Online) 372, n71\u2013n71.","journal-title":"BMJ (Online)"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12179"},{"key":"e_1_3_4_60_2","first-page":"S75","article-title":"Weeding through the haze: a survey on cannabis use among people with Parkinson\u2019s disease","volume":"35","author":"Feeney M","year":"2020","unstructured":"FeeneyM, KlugerB, StoesslA, BegaD, GilbertS, HosangA, OgrenE, SchroederK, EversC, BeckJ (2020) Weeding through the haze: a survey on cannabis use among people with Parkinson\u2019s disease. Mov Disord 35, S75.","journal-title":"Mov Disord"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0104-11692012000200023"},{"key":"e_1_3_4_62_2","first-page":"443","article-title":"Clinical investigation of medicinal products in the treatment of Parkinson\u2019s disease (CPMP note for guidance)","volume":"9","author":"EMEA","year":"1999","unstructured":"EMEA (1999) Clinical investigation of medicinal products in the treatment of Parkinson\u2019s disease (CPMP note for guidance). Eur Neuropsychopharmacol 9, 443\u2013449.","journal-title":"Eur Neuropsychopharmacol"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2011.6"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/18-041"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21228870"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2019-129706"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01259"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1177\/1179544120906461"},{"key":"e_1_3_4_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2019.06.005"},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-016-1329-z"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-181462"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1590\/1516-4446-2018-0333"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2019.03.035"}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JPD-212923","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.3233\/JPD-212923","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JPD-212923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:51:03Z","timestamp":1777611063000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3233\/JPD-212923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,21]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2,15]]}},"alternative-id":["10.3233\/JPD-212923"],"URL":"https:\/\/doi.org\/10.3233\/jpd-212923","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,21]]}}}